FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048856875> ?p ?o ?g. }

• W3048856875 endingPage "51" @default.
• W3048856875 startingPage "43" @default.
• W3048856875 abstract "Abstract Background MRI and PET/CT scans are the main supportive methods for nasopharyngeal cancer (NPC) for staging and planning. The aim of this study is to compare MRI and PET/CT scanning in terms of survival in patients with NPC who had MRI or PET/CT‐simulated radiotherapy planning. Methods Pathological diagnosed nonkeratinized undifferentiated type and stage II‐IVA 91 NPC patients with treated intensity‐modulated radiotherapy plus chemotherapy were scanned. The patients were immobilized by a customized thermoplastic mask for fusion images both MRI scans and PET/CT scans. CTVs were created via MR‐guided simulation and PET/CT‐guided simulation. Results PET/CT‐guided simulation was performed with 44 patients (56.4%) and MR‐guided simulation was performed with 34 patients (43.6%). Local recurrence‐free survival (LRFS) of patients was 68.1 months. LRFS of patients with PET/CT‐guided simulation was 59.9, while LRFS of patients with MR‐guided was 66.9 months. There was a statistically significant difference between groups ( P = .03). In the subgroup analyses, the patients were assessed by dividing into the three groups for the T1‐T2 stage, T‐3 stage, and T‐4 stage. In the patients with T1‐T2 stage, 5‐year LRFS rates were found %74.4 for PET/CT‐guided simulation and %83.3 for MR‐guided simulation. There was no statistically significant difference between groups ( P = .33). In the patients with T‐3 stage, 5‐year LRFS rates were found %55.6 for PET/CT‐guided simulation and %83.3 for MR‐guided simulation. There was not a statistically significant difference between groups ( P = .59). In the patients with T‐4 stage, 5‐year LRFS rates were found %42.2 for PET/CT‐guided simulation and %85.1 for MR‐guided simulation. The difference between groups was found to be statistically significant ( P = .04). Conclusion In this study, we founded that MR‐guided simulation has better than PET/CT‐guided simulation for LRFS." @default.
• W3048856875 created "2020-08-18" @default.
• W3048856875 creator A5037832645 @default.
• W3048856875 creator A5051208511 @default.
• W3048856875 creator A5071764014 @default.
• W3048856875 creator A5078873759 @default.
• W3048856875 date "2020-08-10" @default.
• W3048856875 modified "2023-10-18" @default.
• W3048856875 title "MR‐guided simulation is superior than FDG/PET‐guided simulation for local control in nasopharyngeal cancer patients treated with intensity‐modulated radiotherapy" @default.
• W3048856875 cites W1982142916 @default.
• W3048856875 cites W1986209497 @default.
• W3048856875 cites W1990617102 @default.
• W3048856875 cites W2001030537 @default.
• W3048856875 cites W2019607817 @default.
• W3048856875 cites W2021573820 @default.
• W3048856875 cites W2034219310 @default.
• W3048856875 cites W2040357326 @default.
• W3048856875 cites W2060714085 @default.
• W3048856875 cites W2089417101 @default.
• W3048856875 cites W2097923797 @default.
• W3048856875 cites W2131590442 @default.
• W3048856875 cites W2132411814 @default.
• W3048856875 cites W2136250561 @default.
• W3048856875 cites W2159865368 @default.
• W3048856875 cites W2174306046 @default.
• W3048856875 cites W2509234424 @default.
• W3048856875 cites W2515989760 @default.
• W3048856875 cites W2622219590 @default.
• W3048856875 cites W2624126500 @default.
• W3048856875 cites W2761157533 @default.
• W3048856875 cites W2778272705 @default.
• W3048856875 cites W2791408578 @default.
• W3048856875 doi "https://doi.org/10.1111/ajco.13400" @default.
• W3048856875 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32779400" @default.
• W3048856875 hasPublicationYear "2020" @default.
• W3048856875 type Work @default.
• W3048856875 sameAs 3048856875 @default.
• W3048856875 citedByCount "2" @default.
• W3048856875 countsByYear W30488568752023 @default.
• W3048856875 crossrefType "journal-article" @default.
• W3048856875 hasAuthorship W3048856875A5037832645 @default.
• W3048856875 hasAuthorship W3048856875A5051208511 @default.
• W3048856875 hasAuthorship W3048856875A5071764014 @default.
• W3048856875 hasAuthorship W3048856875A5078873759 @default.
• W3048856875 hasConcept C126838900 @default.
• W3048856875 hasConcept C146357865 @default.
• W3048856875 hasConcept C151730666 @default.
• W3048856875 hasConcept C2778997737 @default.
• W3048856875 hasConcept C2989005 @default.
• W3048856875 hasConcept C509974204 @default.
• W3048856875 hasConcept C71924100 @default.
• W3048856875 hasConcept C86803240 @default.
• W3048856875 hasConceptScore W3048856875C126838900 @default.
• W3048856875 hasConceptScore W3048856875C146357865 @default.
• W3048856875 hasConceptScore W3048856875C151730666 @default.
• W3048856875 hasConceptScore W3048856875C2778997737 @default.
• W3048856875 hasConceptScore W3048856875C2989005 @default.
• W3048856875 hasConceptScore W3048856875C509974204 @default.
• W3048856875 hasConceptScore W3048856875C71924100 @default.
• W3048856875 hasConceptScore W3048856875C86803240 @default.
• W3048856875 hasIssue "1" @default.
• W3048856875 hasLocation W30488568751 @default.
• W3048856875 hasOpenAccess W3048856875 @default.
• W3048856875 hasPrimaryLocation W30488568751 @default.
• W3048856875 hasRelatedWork W2052574963 @default.
• W3048856875 hasRelatedWork W2170413290 @default.
• W3048856875 hasRelatedWork W2349233961 @default.
• W3048856875 hasRelatedWork W2356304706 @default.
• W3048856875 hasRelatedWork W2370948200 @default.
• W3048856875 hasRelatedWork W2380330452 @default.
• W3048856875 hasRelatedWork W2384038617 @default.
• W3048856875 hasRelatedWork W3023095530 @default.
• W3048856875 hasRelatedWork W4362480766 @default.
• W3048856875 hasRelatedWork W4362480788 @default.
• W3048856875 hasVolume "17" @default.
• W3048856875 isParatext "false" @default.
• W3048856875 isRetracted "false" @default.
• W3048856875 magId "3048856875" @default.
• W3048856875 workType "article" @default.